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2Introduction
Soft tissue sarcomas are rare (estimated incidence
3-4.5/100 000).1 Five pour-cents of all soft tissue
sarcomas arise in the head and neck region.1–3 Lit-
tle is known about aetiology, prognostic factors
and treatment results of those cancers.1–3
About 3% of all soft tissue sarcomas are associ-
ated with genetic disease, essentially Recklinghau-
sen disease. Others genetic diseases are741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
oi:10.1016/j.ooe.2005.07.004
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E-mail address: n-penel@o-lambret.fr (N. Penel).exceptionally associated with soft tissue sarcomas:
polypadenatous coli, Werner syndrome, bilateral
retinoblastoma . . .1
We describe herein an association of head and
neck angiosarcoma and nevoid basal cell carcinoma
syndrome (NBCC syndrome).Case report
A 41-year-old man was refereed for management of
a large tumour of neck muscles (Fig. 1). The tumour
had appeared 3 months before on the left side of
the neck, was painless, and showed a rapid initialrved.
Figure 1 Eighteen FDG-positron emission tomography:
initial locoregional extension of the angiosarcoma.
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cal examination revealed an epithelioid angiosar-
coma. Further evaluation with head and neck CT
scan and positron emission tomography revealed
an 8 cm necrotic tumour with multiple lymph nodes
extension (supra-clavicular and upper mediasti-
num) and large involvement of neck muscles.
This patient presented with previous history of
sporadic NBCC syndrome, with macrocephaly due
to Arnold–Chiari malformation, multiple kera-
tocysts of the jaw and 12 previous basal cell carci-
nomas of face and chest treated by surgery.
The angiosarcoma was considered as inopera-
ble. Thus, the patient received two cycles of
polychemotherapy regimen including adriamycin,
ifosfamid and dacarbazine. Despite the chemother-
apy, we observed a rapid growth, with apparition
of controlateral lymph node extension, involve-
ment into upper mediastinum and liver metastases.
A second-line chemotherapy with paclitaxel failed
to stop the progression and the patient died
3 months after diagnosis.Discussion
The nevoid basal cell carcinoma syndrome (NBCC),
also known as Gorlin syndrome and the basal cell
nevus syndrome, is an autosomal dominant disor-
der that predisposes to basal cell carcinoma (BCCs)of the skin, medullobastomas, and ovarian fibro-
mas.4 Its prevalence has been estimated at 1 per
56000. One to 2% of medulloblastomas and 0.5%
of basal cell carcinomas are attributable to the
syndrome.4–6
BCCs in this disorder are multiple, occur rela-
tively early compared with sporadic tumours of
the same type, and tend to develop after exposure
to ionizing radiation with a very brief latency peri-
od.4–7
In addition to benign and malignant tumours,
malformations are a striking component. The syn-
drome is associated with pits of the palms and
soles, keratocysts of the jaw and other dental
malformations, cleft palate, characteristics coarse
facies, strabismus, dysgenesis of corpsus callosum,
calcification of the falx cerebri, spina bifida occ-
ulta and other spine anomalies, bifid ribs, ectopic
calcifications, mesenteric cysts, macrocephaly
and generalized overgrowth.4–7
The extent of expression of the many features of
the syndrome is variable, but the severity tends to
breed true within families. There are occasional
sporadic cases. The behaviour of tumours in NBCC
suggests that the underlying defect in this disorder
may be a mutation in a tumour suppressor gene.
Mapping of the NBCC gene to chromosome 9 and
the demonstration of the exact same region is de-
leted in a high percentage of BCCs and other tu-
mours related to the disorder provided strong
evidence of this gene may be a necessary if not suf-
ficient event for the development of BCCs.8
The diagnosis of NBCC should be considered in
anyone below the age of 30 with a single BCC and
in older individuals with multiple BCCs. Medullo-
blastomas, keratocysts of the jaw and typical skel-
etal anomalies should raise the suspicion of NBCC
even in absence of BCCs. Palmar and plantar pits
are pathognomonic.
The most important follow-up study in affected
individuals is dermatologic examination for BCCs
at intervals of 6 months to 1 year.7
Head and neck soft tissue sarcomas are rare.1–3
Their treatment required a large resection in a
multimodal approach. Actually, theirs pseudocap-
sules represent an artificial and inadequate limit.
Those cancers spread along facial planes, muscles,
nerves and vessels, and reduce the possibility of
resection with adequate margins. So, the prognosis
of head and neck soft tissue sarcoma is poor.2,3
Two histological subtypes are particularly fre-
quent in head and neck: rhabdomyosarcoma
and angiosarcoma.2,3 Multicentric angiosarcoma
occurs in the scalp and the face of elderly men,
where unrelenting progression can cause severe
ulceration and infection. Surgical treatment is not
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therapy and chemotherapy are indicated.9,10
Angiosarcomas represent 1% of all soft tissue
sarcomas. Their clinical outcomes are poor due to
a rapid growth, with high risk of metastatic exten-
sion. The median overall survival of all clinical
types of angiosarcomas is ranged between 15 and
30 months.11
Adriamycin and ifosfamid-based regimen
achieve a response rate about 30% for metastatic
or locally advanced soft tissue sarcoma.1 Paclitaxel
seems to be effective for treatment of scalp
angiosarcoma.10
Our case report show the poor outcome of lo-
cally advanced head and neck soft tissue sarcoma,
especially head and neck angiosarcoma. Associa-
tion NBCC syndrome and angiosarcoma was not
previously described. In NBCC, other soft tissue
tumours probably occur to excess include fibrosar-
comas, rhabdomyosarcomas, and cardiac fibroma.
To conclude, in patient with previous history of
Gorlin syndrome, the apparition of a soft tissue tu-
mour requires absolutely a biopsy in order to treat
early a soft tissue sarcoma.References
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